Companies Dominating the Smart Pills Patient Monitoring Landscape
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
AbbVie Inc
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2024, the industry size of smart pills patient monitoring is evaluated at USD 6.63 Billion.
The smart pills patient monitoring market size was over USD 5.8 Billion in 2023 and is expected to exceed USD 39.46 Billion by the end of 2036, witnessing over 15.9% CAGR during the forecast period i.e., between 2024-2036. Increasing ratio of various types of chronic disorders, rising prevalence of gastrointestinal reflux disease (GERD), and worldwide increase in neurological disorders are the major factors driving the market growth.
North America is likely to dominate majority industry share by 2036, attributed to higher frequency of colorectal cancer amongst people, driven by rise in sedentary lifestyles, and rapidly surging ratio of geriatric populace in the region.
Medtronic plc, AbbVie Inc., Novartis AG, CapsoVision, Inc., Medimetrics, SA de CV, TauRx Pharmaceuticals Ltd, Otsuka Pharmaceutical Co. Ltd., FUJIFILM Holdings Corporation,
